🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Attending a meeting to improve the effectiveness of the public malaria treatment system lead by Indonesian malaria experts and Menzies => very inspiring!

Could face masks support immunization against Covid 19?Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine | NEJM nejm.org/doi/full/10.10…

Large variation in G6PD deficiency prevalence within a multi ethnic setting in Bangladesh supports routine testing to guide Pq based radical cure journals.plos.org/plosntds/artic…

Congratulations Ric Price, very well deserved!!

Is G6PD activity increased at clinically relevant levels in the course of an acute malaria episode? We think so. journals.plos.org/plosmedicine/a…

November is National Marrow Awareness Month. So congratulations to Dr. Benedikt Ley [benedikt_ley] of Charles Darwin University -- Recognized as an Expertscape World Expert in Glucosephosphate Dehydrogenase Deficiency. expertscape.com/ex/glucosephos…

Excited to share our latest article published in @plosntds: journals.plos.org/plosntds/artic… #plosntdsauthor showing that under optimal conditions the G6PD STANDARD by SD BIOSENSOR shows very good reproducibility

pubmed.ncbi.nlm.nih.gov/35544453/ The first ever longitudinal study that suggests that G6PD activity increases at clinically relevant levels in malaria patients. This may render radical cure much safer than assumed to date. Thanks to all my colleagues who contributed!

Our latest meta-analysis describing G6PD activities / G6PD variant is published and supports WHO calls to revise the current G6PD classification. Many thanks to all authors! mdpi.com/2076-0817/11/9…

5 malariajournal.biomedcentral.com/articles/10.11…

ASEAN/DFAT funded: Very excited to be part of the first Humasis G6PD RDT systematic field evaluation with my colleague Dr Ari Winasti Satyagraha in Indonesia - are we looking at a new diagnostic for vivax radical cure? Department of Foreign Affairs and Trade 🇦🇺 Humasis Korean

How were clinical trials adapted during COVID-19 and what are the implications of adaptations? We share our experience on benefits and challenges of trial-adaptations during the pandemic: #clinicaltrials #COVID19 journals.sagepub.com/doi/10.1177/17…

Are village malaria workers competent enough to use biosensors? Is community-based management of vivax malaria feasible? Please read findings from our operational research that provides pragmatic answers to those questions: mdpi.com/2076-0817/12/3… @MORUBkk Tropical Medicine Oxford #G6PD

On #WorldMalariaDay 2023 we say #TimetoDeliverZeroMalaria, MAP is committed to continuing the fight against malaria, see how our team are creating #innovative tools to help #EndMalaria malariaatlas.org

What is the state of G6PD testing at the point of care worldwide? Find out here: A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria mdpi.com/2269460 #mdpipathogens via Pathogens MDPI Kamala Thriemer

NEW STUDY | A new international research collaboration led by Menzies Senior Research Fellow, Dr Benedikt Ley is set to examine whether the risk of severe side effects from vivax malaria medication, primaquine, is lower than assumed to date. Read more: bit.ly/49U6sjr

Menzies Principal Research Fellow Benedikt Ley visited Karachi to introduce the IMPACT study & explore the Thatta field site.Funded by an Ideas Grant, the study aims to assess G6PD deficiency risk in vivax malaria treatment-key to improving patient safety & treatment strategies

Safer malaria treatment starts with reliable G6PD testing. A new meta-analysis shows significant performance differences across point-of-care devices, impacting safe radical cure for P. vivax. Global scale-up of accurate testing is urgently needed. doi.org/10.1371/journa…